Tempus AI (NASDAQ:TEM) Trading 2.6% Higher - Should You Buy?

Tempus AI, Inc. (NASDAQ:TEM - Get Free Report)'s stock price was up 2.6% on Monday . The company traded as high as $59.08 and last traded at $58.35. Approximately 2,676,169 shares changed hands during mid-day trading, a decline of 64% from the average daily volume of 7,528,381 shares. The stock had previously closed at $56.88.

Wall Street Analyst Weigh In

A number of analysts recently issued reports on TEM shares. BTIG Research started coverage on shares of Tempus AI in a research report on Monday, April 21st. They set a "buy" rating and a $60.00 target price on the stock. Morgan Stanley lifted their price objective on Tempus AI from $60.00 to $65.00 and gave the company an "overweight" rating in a research report on Friday, May 9th. Bank of America increased their target price on Tempus AI from $68.00 to $70.00 and gave the stock a "neutral" rating in a research report on Wednesday, June 25th. Needham & Company LLC restated a "buy" rating and issued a $70.00 price target on shares of Tempus AI in a report on Wednesday, May 7th. Finally, Piper Sandler increased their price objective on shares of Tempus AI from $55.00 to $70.00 and gave the stock a "neutral" rating in a report on Thursday, May 15th. Six equities research analysts have rated the stock with a hold rating and six have issued a buy rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average target price of $65.09.

Tempus AI Trading Up 1.1%

The business's 50-day moving average is $63.15 and its two-hundred day moving average is $55.27. The company has a current ratio of 1.71, a quick ratio of 1.56 and a debt-to-equity ratio of 2.45. The stock has a market capitalization of $10.50 billion and a PE ratio of -7.78.

Tempus AI (NASDAQ:TEM - Get Free Report) last posted its earnings results on Tuesday, May 6th. The company reported ($0.24) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.27) by $0.03. The business had revenue of $255.74 million during the quarter, compared to analyst estimates of $248.13 million. Tempus AI had a negative return on equity of 533.21% and a negative net margin of 88.27%. The company's revenue for the quarter was up 75.4% on a year-over-year basis. On average, analysts predict that Tempus AI, Inc. will post -6.15 earnings per share for the current year.

Insider Buying and Selling at Tempus AI

In other Tempus AI news, EVP Erik Phelps sold 51,317 shares of the business's stock in a transaction on Monday, June 16th. The shares were sold at an average price of $72.56, for a total value of $3,723,561.52. Following the transaction, the executive vice president owned 97,779 shares in the company, valued at $7,094,844.24. The trade was a 34.42% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Theodore Leonsis sold 205,847 shares of Tempus AI stock in a transaction dated Wednesday, June 11th. The stock was sold at an average price of $67.66, for a total value of $13,927,608.02. Following the sale, the director directly owned 15,511 shares in the company, valued at approximately $1,049,474.26. The trade was a 92.99% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders sold 612,522 shares of company stock worth $41,600,238. 27.60% of the stock is currently owned by insiders.

Institutional Trading of Tempus AI

Hedge funds have recently made changes to their positions in the stock. Bank of New York Mellon Corp bought a new stake in shares of Tempus AI in the 4th quarter valued at approximately $1,615,000. Victory Capital Management Inc. acquired a new position in Tempus AI in the fourth quarter worth $216,000. Raymond James Financial Inc. bought a new stake in Tempus AI during the fourth quarter valued at $3,757,000. Farther Finance Advisors LLC acquired a new stake in shares of Tempus AI during the fourth quarter worth $34,000. Finally, Axxcess Wealth Management LLC bought a new position in shares of Tempus AI in the 4th quarter worth about $221,000. Institutional investors and hedge funds own 24.22% of the company's stock.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.